Abstract
Background The problem of predicting loss in body height due to scoliosis especially in adolescent idiopathic scoliosis (AIS) has been investigated for over 50 years. The corrected height is required to make appropriate lung function and other anthropometry assessments. Most existing formulae estimate height loss through different regression models.
Method A new trigonometric model was developed based on the Cobb angle (α) and the apical vertebral translation (AVT) in the coronal plane. By using this model, a formula was derived using the tangent of the triangle to estimate height loss in Scoliosis.
As measurement of AVT is not commonly performed, a mean value was obtained from patients series reported by Şarlak et al. It was found that AVT is affected by the Cobb angle, which was significantly different between patients with Cobb angle >= 50 and < 50.
Results Validation of this new Tangent formula was carried out with two datasets, one from Tyrakowski et al 2014, and another from 58 operated Scoliosis patients in a local hospital. The mean bias was the lowest with this novel tangent formula compared to Bjure, Kono, Stokes formulae. A paired t-test confirmed that these differences were significantly better with the tangent formula. The trigonometric approach has the advantage that it is valid over a larger range of Cobb angle as most of the regression models cannot be extrapolated outside the range of available data points.
The Tangent formula is made available at the website for easy access and height loss can be estimated by inputting the Cobb angle with or without the AVT: https://tangentformulae.scoliosisdevices.com/
Conclusion The results indicate the use of the Tangent formula with simple measurements and trigonometric calculation yield results comparable with other formulae used in the past to estimate height loss. The application of this new formula can prove useful in clinical settings to allow more accurate testing and better care for patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by a General Research fund for RGC in Hong Kong.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of The Chinese University of Hong Kong gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos